Peter Hanson work email
- Valid
- Valid
- Valid
Peter Hanson personal email
Peter Hanson phone numbers
My passion is to make significant positive impact to the lives of people and animals. Starting as a practicing veterinarian and moving into pharma and human biotech executive leadership, I've developed and led cross-functional teams through critical growth phases - from early-stage research through clinical development and commercial launch, driven operational excellence and capital market readiness, and have been central to strategic partnerships and corporate integrations. My approach centers on creating collaborative environments to foster team alignment and advance innovation while building sustainable value for organizations.
-
Co-FounderVetrixbio, Inc. May 2024 - PresentAt VetrixBio, we are developing next generation medicines for two of the most common and disabling diseases in dogs: cancer and osteoarthritis (OA). More than 4.2 million dogs annually are diagnosed with cancer and the standard of care (SOC) today relies on dated chemotherapy and radiation. Efficacy is often limited, and serious adverse events are common. We intend to change that.OA affects as many as 40% of young dogs and 80% of dogs aged 8 years and older, with the SOC limited to pain relief rather than treating the underlying disease. We are adding disease modification to pain management.
-
Venture PartnerAnterra Capital Oct 2023 - PresentAmsterdam, NlAnterra identifies next-generation science for major therapeutic targets in animal health on which to launch the next portfolio company.
-
Executive ConsultantSpruce Biotech Consulting, Llc Mar 2023 - PresentWith more than 28 years experience in veterinary pharma and human biotech, I provide consulting on biotechnology research, clinical development, manufacturing and business operations, including IPO readiness. -
Chief Operating OfficerEgenesis, Inc. Jul 2020 - Feb 2023Cambridge, Ma, UseGenesis is advancing the field of transplantation to make available safe and reliable xeno organs, tissues, and cells to patients in need. This is done through gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation to date. -
Chief Development Operations OfficerCentrexion Therapeutics Corp. Jun 2014 - Jun 2020Boston, Ma, UsCentrexion is pioneering new treatments to relieve the suffering associated with chronic pain by developing non-opioid and non-addictive therapies. -
Head, R&D And Medical Affairs, Animal HealthAbbott Dec 2012 - Jun 2014Abbott Park, Illinois, UsOur vision was to be recognized for consistently setting new standards in healthcare solutions that enrich the human/pet bond. Our programs included the areas of pain, oncology and medical devices. -
Global Head, Project & Portfolio ManagementMerial May 2011 - Dec 2012Ingelheim Am Rhein, Rhineland-Palatinate, DeResponsible for the team of project leaders and project managers for the company's portfolio of veterinary pharmaceutical and vaccine development projects. Scope was global. -
Head Of Pharma R&DMerial Oct 2007 - May 2011Ingelheim Am Rhein, Rhineland-Palatinate, DeResponsible for discovery screening, chemical development, formulation development, analytical development, and DMPK for small molecule pharmaceutical projects.
-
Executive Director, Sr Director, Director, Project Leader, Assoc DirectorMerial Oct 1996 - Sep 2007Ingelheim Am Rhein, Rhineland-Palatinate, DeLed development of PREVICOX and EQUIOXX to global approvals and a team of other project leaders.
-
Resident, Fellow, LecturerUniversity Of Wisconsin-Madison 1990 - 1996Madison, Wi, UsResidency in large animal surgery. Graduate work in bone biomechanics and bone transplantation/healing, leading to MS and PhD. Lectured in large animal anatomy. -
Associate VeterinarianEquine/Small Animal Medical Center (Lakeville, Mn) 1989 - 1990Associate veterinarian with a split 70% equine and 30% small animal.
Peter Hanson Skills
Peter Hanson Education Details
-
University Of Wisconsin-MadisonVeterinary Science And Large Animal Surgery -
University Of MinnesotaBa Summa Cum Laude - Biology
Frequently Asked Questions about Peter Hanson
What company does Peter Hanson work for?
Peter Hanson works for Anterra Capital
What is Peter Hanson's role at the current company?
Peter Hanson's current role is Biotech/Pharma Executive and Entrepreneur.
What is Peter Hanson's email address?
Peter Hanson's email address is ph****@****ion.com
What is Peter Hanson's direct phone number?
Peter Hanson's direct phone number is +141052*****
What schools did Peter Hanson attend?
Peter Hanson attended University Of Wisconsin-Madison, University Of Minnesota.
What skills is Peter Hanson known for?
Peter Hanson has skills like Pharmaceutical Industry, R&d, Gmp, Veterinary Medicine, Biotechnology, Small Molecules, Chemical Engineering.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial